Healthy Extracts (HYEX)
OTHER OTC:HYEX
Want to see HYEX full AI Analyst Report?
HYEX Stock Chart & Stats
$1.97
$0.00(0.00%)
At close: 4:00 PM EST
$1.97
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.81 - $4.25
Previous CloseN/A
Volume1.00
Average Volume (3M)1.29K
Market Cap
$21.11M
Enterprise Value$6.33M
Total Cash (Recent Filing)$146.94K
Total Debt (Recent Filing)$2.64M
Price to Earnings (P/E)―
Beta1.40
Next Earnings
May 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding16,890,867
10 Day Avg. Volume902
30 Day Avg. Volume1,290
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.59
Price to Sales (P/S)3.13
P/FCF Ratio96.73
Enterprise Value/Market Cap0.30
Enterprise Value/Revenue1.40
Enterprise Value/Gross Profit2.61
Enterprise Value/Ebitda-8.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.13
Revenue Forecast (FY)$14.12M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthMulti-year revenue expansion (nearly 3.5x since 2020 and mid-20% growth in 2025) indicates durable market adoption and expanding customer traction. This scale improvement provides a firmer base for incremental operating leverage and supports longer-term investment in product and commercial capability.
Improving Gross MarginA meaningful rise in gross margin to ~53.7% reflects better pricing, mix, or cost control and increases the company's margin buffer. Higher gross margins make profitability more attainable as revenue grows, enhancing structural earnings power if sustained across product lines and markets.
Positive Operating & Free Cash FlowTransitioning to positive operating and free cash flow in recent years signals improving cash generation and lower near-term reliance on external funding. Consistent positive cash flow supports reinvestment, debt service and gives management flexibility to fund growth without immediate dilution if the trend holds.
Bears Say
Ongoing UnprofitabilityPersistent negative net margins (~-19.5% in 2025) mean the business still requires structural improvements to deliver sustainable profitability. Losses limit retained capital, increase dependence on external financing, and mean that earnings power remains unproven despite revenue and margin gains.
Uneven Cash-Flow QualityVolatile cash flows and a sharp FCF decline in 2025 versus 2024, plus historical burn through 2020–2023, indicate execution and timing risk. This unevenness can force opportunistic financing, constrain R&D or commercial spend, and raises the chance of funding stress during down cycles.
Very Small Operating ScaleA two-person headcount signals limited operational bandwidth, high key-person risk, and constrained capacity to scale sales, regulatory, or manufacturing efforts. Small organizational scale can slow commercialization, increase execution risk, and make sustaining growth or responding to setbacks harder.
Healthy Extracts News
HYEX FAQ
What was Healthy Extracts’s price range in the past 12 months?
Healthy Extracts lowest stock price was $0.81 and its highest was $4.25 in the past 12 months.
What is Healthy Extracts’s market cap?
Healthy Extracts’s market cap is $21.11M.
When is Healthy Extracts’s upcoming earnings report date?
Healthy Extracts’s upcoming earnings report date is May 18, 2026 which is in 12 days.
How were Healthy Extracts’s earnings last quarter?
Healthy Extracts released its earnings results on Apr 08, 2026. The company reported -$0.009 earnings per share for the quarter, missing the consensus estimate of $0 by -$0.009.
Is Healthy Extracts overvalued?
According to Wall Street analysts Healthy Extracts’s price is currently Overvalued.
Does Healthy Extracts pay dividends?
Healthy Extracts does not currently pay dividends.
What is Healthy Extracts’s EPS estimate?
Healthy Extracts’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Healthy Extracts have?
Healthy Extracts has 16,890,867 shares outstanding.
What happened to Healthy Extracts’s price movement after its last earnings report?
Healthy Extracts reported an EPS of -$0.009 in its last earnings report, missing expectations of $0. Following the earnings report the stock price went down -35.24%.
Which hedge fund is a major shareholder of Healthy Extracts?
Currently, no hedge funds are holding shares in HYEX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Healthy Extracts
Healthy Extracts Inc., through its subsidiaries, researches, develops, and markets natural plant-based products in the United States and internationally. It offers heart health nutritional supplements; and neuro products under the KETONOMICS name that enhance brain health, including memory, cognition, focus, and neuro-energy. The company also provides bergamot products in capsule form under the BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART products labels. It distributes bergamot products through its website and distribution sites. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is based in Littleton, Colorado.
Technical Analysis
Rockwell Med
―
SCYNEXIS
―
Aytu BioScience
―
Cumberland Pharmaceuticals
―
Cosmos Holdings
―
Ownership Overview
Options Prices
Currently, No data available
---